Cookies: We use cookies to give you the best possible experience on our site. By continuing to use the site you agree to our use of cookies. Find out more
House of Commons Hansard
x
11 November 2009
Volume 499
The edit just sent has not been saved. The following error was returned:
This content has already been edited and is awaiting review.

To ask the Secretary of State for Health what drugs used in the NHS are known to have teratogenic effects; and if he will make a statement. [297456]

The edit just sent has not been saved. The following error was returned:
This content has already been edited and is awaiting review.

Drugs can have harmful effects (teratogenic effects) on the foetus at any time during pregnancy, with the period of greatest risk being from the third to the eleventh week of pregnancy.

The safety, efficacy and quality of each new medicine is thoroughly evaluated as part of the licensing procedure. European guidelines define the types of tests which should be undertaken, including those that assess the potential harm to a developing foetus.

The available information is reflected in the product information for each medicine which contains a specific section that summarises the information in relation to safety of use during pregnancy. This is kept under review to ensure patients and prescribers are given accurate up to date information. A summary source of this information is appendix 4 of the British National Formulary (BNF). The BNF is provided free to prescribers and pharmacists within the NHS.